Minneapolis-based Medtronic is preparing to sell part or all of its medical supplies business, an unnamed source told Bloomberg.
While Medtronic has sought prospective buyers for the unit, arrangements are still in early stages, the source said.
The medical supply unit, which sells everything from needles to monitoring equipment, could be valued at up to $5 billion. The sale would mainly offload assets Medtronic gained through its $42.9 billion acquisition of Covidien in 2014, according to the report.
It's unknown whether Medtronic will sell the medical supplies unit as a whole or split the unit into smaller divestitures, reports Bloomberg.
A Medtronic spokesman told Becker's the company does not comment on rumors of divestitures.
More articles on supply chain:
Shifting drug production back to US could raise prices: 5 takeaways
5 ways to prepare your supply chain for a disaster
Mayo Clinic physician: A stripped down FDA would be 'chaotic'